05/14/2026
One of the most interesting shifts happening in medicine right now isn’t just about new treatments… in fact, it’s about rethinking the frameworks we inherited.
For decades, many conditions were named based on what medicine could observe at the time: anatomy, visible findings, isolated symptoms. But as research evolves, we’re realizing that some diagnoses may represent far more complex systemic processes than their names originally implied.
The recent debate around renaming PCOS to PMOS is a perfect example. Not because changing an acronym magically changes outcomes, but because it reflects a broader shift in how we understand disease.
And honestly, I’ve always thought many pelvic pain syndromes raise similar questions….like interstitial cystitis.
The term itself implies a bladder-centric inflammatory condition. But in clinical practice, many patients don’t fit neatly into a single-organ model. What we often see instead is a far more complex interplay between the nervous system, pelvic floor musculature, immune signaling, hormonal influences, stress physiology, and chronic pain processing.
That doesn’t mean the bladder isn’t involved.
It means the story may be bigger than the name suggests.
Medicine has always evolved this way: first observation, then pattern recognition, then deeper mechanistic understanding.
The challenge is that terminology often fossilizes somewhere in the middle.
And at a certain point, outdated language doesn’t just reflect old science, it shapes the way patients are understood, researched, and treated.
So the larger question becomes:
How do we preserve diagnostic clarity while still allowing our understanding of disease to evolve? 🤔 just some of my stream of consciousness thoughts 🤨
